Table 2 Impact of pulmonary infection on outcome events in the multivariate logistic regression analysis.

From: Impact of pulmonary infection and antibiotic use on recurrent myocardial infarction in patients with myocardial infarction

Exposure

NSTEMI

STEMI

Total

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Model A

 Pulmonary infection

      

 NO

Ref.

 

Ref.

 

Ref.

 

 YES

1.47 (1.22, 1.79)

< 0.0001

1.43 (1.15, 1.80)

0.0016

1.46 (1.26, 1.69)

< 0.0001

Model B

 Pulmonary infection

      

 NO

Ref.

 

Ref.

 

Ref.

 

 YES

1.48 (1.22, 1.80)

< 0.0001

1.47 (1.17, 1.85)

0.0009

1.48 (1.28, 1.72)

< 0.0001

Model C

 Pulmonary infection

      

 NO

Ref.

 

Ref.

 

Ref.

 

 YES

1.35 (1.09, 1.66)

0.0052

1.50 (1.18, 1.92)

0.0011

1.42 (1.21, 1.66)

< 0.0001

Model D

 Pulmonary infection

      

 NO

Ref.

 

Ref.

 

Ref.

 

 YES

1.23 (0.95, 1.58)

0.1164

1.21 (0.91, 1.61)

0.2004

1.22 (1.01, 1.47)

0.0429

  1. Bold represent significant values (p < 0.05).
  2. Abbreviations: OR: odds Ratio; CI: confidence interval; Ref: reference.
  3. Model A adjust for: None.
  4. Model B adjust for: Sex; Age.
  5. Model C adjust for: Sex; Age; BMI; LVEF; NTproBNP; Troponin T; Low-Density Lipoprotein; PCI; Killip classification; Auricular fibrillation; Valvular heart disease; Previous myocardial infarction; Hypertension; Diabetes mellitus; COPD; Renal insufficiency; Stroke; Antiplatelet drugs; Number of antiplatelet agents; Statins; β-blockers; Novel oral anticoagulants; Warfarin.
  6. Model D adjust for: Antibiotics.
Back to article page